chr3-45958418-T-C

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_024513.4(FYCO1):​c.3789A>G​(p.Thr1263Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0311 in 1,612,242 control chromosomes in the GnomAD database, including 886 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 76 hom., cov: 33)
Exomes 𝑓: 0.032 ( 810 hom. )

Consequence

FYCO1
NM_024513.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.140

Publications

4 publications found
Variant links:
Genes affected
FYCO1 (HGNC:14673): (FYVE and coiled-coil domain autophagy adaptor 1) The gene encodes a Rab7 adapter protein that is implicated in the microtubule transport of autophagosomes. The encoded protein contains a RUN domain, a FYVE-type zinc finger domain, and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P), the autophagosome marker LC3, and the kinesin KIF5. Mutations in this gene are associated with inclusion body myositis (IBM) and autosomal recessive congenital cataracts (CATC2). [provided by RefSeq, Aug 2020]
FYCO1 Gene-Disease associations (from GenCC):
  • cataract 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • total early-onset cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.02).
BP6
Variant 3-45958418-T-C is Benign according to our data. Variant chr3-45958418-T-C is described in ClinVar as Benign. ClinVar VariationId is 345501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0258 (3935/152350) while in subpopulation NFE AF = 0.0386 (2623/68028). AF 95% confidence interval is 0.0373. There are 76 homozygotes in GnomAd4. There are 1890 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 76 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FYCO1NM_024513.4 linkc.3789A>G p.Thr1263Thr synonymous_variant Exon 13 of 18 ENST00000296137.7 NP_078789.2 Q9BQS8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FYCO1ENST00000296137.7 linkc.3789A>G p.Thr1263Thr synonymous_variant Exon 13 of 18 1 NM_024513.4 ENSP00000296137.2 Q9BQS8-1
FYCO1ENST00000433878.5 linkc.153A>G p.Thr51Thr synonymous_variant Exon 1 of 7 2 ENSP00000388136.1 H7BZ74
FYCO1ENST00000438446.1 linkc.-199A>G 5_prime_UTR_variant Exon 1 of 6 5 ENSP00000398517.1 C9J2W6

Frequencies

GnomAD3 genomes
AF:
0.0259
AC:
3938
AN:
152232
Hom.:
76
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00627
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0277
Gnomad ASJ
AF:
0.0277
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00620
Gnomad FIN
AF:
0.0396
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0386
Gnomad OTH
AF:
0.0325
GnomAD2 exomes
AF:
0.0287
AC:
7143
AN:
249260
AF XY:
0.0289
show subpopulations
Gnomad AFR exome
AF:
0.00520
Gnomad AMR exome
AF:
0.0237
Gnomad ASJ exome
AF:
0.0309
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0403
Gnomad NFE exome
AF:
0.0417
Gnomad OTH exome
AF:
0.0351
GnomAD4 exome
AF:
0.0317
AC:
46206
AN:
1459892
Hom.:
810
Cov.:
32
AF XY:
0.0312
AC XY:
22693
AN XY:
726226
show subpopulations
African (AFR)
AF:
0.00464
AC:
155
AN:
33420
American (AMR)
AF:
0.0253
AC:
1129
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
837
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00721
AC:
621
AN:
86134
European-Finnish (FIN)
AF:
0.0421
AC:
2243
AN:
53314
Middle Eastern (MID)
AF:
0.0380
AC:
170
AN:
4476
European-Non Finnish (NFE)
AF:
0.0353
AC:
39293
AN:
1111826
Other (OTH)
AF:
0.0292
AC:
1757
AN:
60228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2390
4780
7171
9561
11951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1374
2748
4122
5496
6870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0258
AC:
3935
AN:
152350
Hom.:
76
Cov.:
33
AF XY:
0.0254
AC XY:
1890
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00625
AC:
260
AN:
41592
American (AMR)
AF:
0.0277
AC:
424
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
96
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00579
AC:
28
AN:
4832
European-Finnish (FIN)
AF:
0.0396
AC:
421
AN:
10620
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0386
AC:
2623
AN:
68028
Other (OTH)
AF:
0.0317
AC:
67
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
198
397
595
794
992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0340
Hom.:
210
Bravo
AF:
0.0244
Asia WGS
AF:
0.00664
AC:
23
AN:
3478
EpiCase
AF:
0.0403
EpiControl
AF:
0.0377

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cataract 18 Benign:2
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.9
DANN
Benign
0.37
PhyloP100
-0.14
PromoterAI
-0.021
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41289618; hg19: chr3-45999910; API